Literature DB >> 12897125

Alternative splicing controls myotonic dystrophy protein kinase structure, enzymatic activity, and subcellular localization.

Derick G Wansink1, René E M A van Herpen, Marga M Coerwinkel-Driessen, Patricia J T A Groenen, Brian A Hemmings, Bé Wieringa.   

Abstract

Transcripts of the myotonic dystrophy protein kinase (DMPK) gene, a member of the Rho kinase family, are subject to cell-type specific alternative splicing. An imbalance in the splice isoform profile of DMPK may play a role in the pathogenesis of DM1, a severe multisystemic disorder. Here, we report how structural subdomains determine biochemical properties and subcellular distribution of DMPK isoforms. A newly developed kinase assay revealed that DMPK is a Lys/Arg-directed kinase. Individual DMPK isoforms displayed comparable transphosphorylation activity and sequence preference for peptide substrates. However, DMPK autophosphorylation and phosphorylation of MYPT1 (as putative in vivo target of DMPK), were dependent on presence of an alternatively spliced VSGGG motif and the nature of the C terminus. In-gel effects of the VSGGG motif on the migration behavior of full-length kinase provide evidence for a model in which this motif mediates 3-D-conformational changes in DMPK isoforms. Finally, different C termini endow DMPK with the ability to bind to either endoplasmic reticulum or mitochondria or to adopt a cytosolic location. Our results suggest that DMPK isoforms have cell-type and location dependent substrate specificities with a role in organellar and cytoarchitectural dynamics.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12897125      PMCID: PMC166319          DOI: 10.1128/MCB.23.16.5489-5501.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  55 in total

Review 1.  Regulation and functions of Rho-associated kinase.

Authors:  M Amano; Y Fukata; K Kaibuchi
Journal:  Exp Cell Res       Date:  2000-11-25       Impact factor: 3.905

2.  Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy.

Authors:  R S Savkur; A V Philips; T A Cooper
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

3.  Myotonic dystrophy: the role of the CUG triplet repeats in splicing of a novel DMPK exon and altered cytoplasmic DMPK mRNA isoform ratios.

Authors:  G Tiscornia; M S Mahadevan
Journal:  Mol Cell       Date:  2000-06       Impact factor: 17.970

4.  Skeletal muscle sodium channel gating in mice deficient in myotonic dystrophy protein kinase.

Authors:  J P Mounsey; D J Mistry; C W Ai; S Reddy; J R Moorman
Journal:  Hum Mol Genet       Date:  2000-09-22       Impact factor: 6.150

Review 5.  Myotonic dystrophy and myotonic dystrophy protein kinase.

Authors:  H Ueda; S Ohno; T Kobayashi
Journal:  Prog Histochem Cytochem       Date:  2000

6.  Two splice variants of protein kinase B gamma have different regulatory capacity depending on the presence or absence of the regulatory phosphorylation site serine 472 in the carboxyl-terminal hydrophobic domain.

Authors:  D Brodbeck; M M Hill; B A Hemmings
Journal:  J Biol Chem       Date:  2001-05-31       Impact factor: 5.157

7.  Peptide and protein library screening defines optimal substrate motifs for AKT/PKB.

Authors:  T Obata; M B Yaffe; G G Leparc; E T Piro; H Maegawa; A Kashiwagi; R Kikkawa; L C Cantley
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

8.  DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model.

Authors:  C I Berul; C T Maguire; M J Aronovitz; J Greenwood; C Miller; J Gehrmann; D Housman; M E Mendelsohn; S Reddy
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

9.  Intermolecular and intramolecular interactions regulate catalytic activity of myotonic dystrophy kinase-related Cdc42-binding kinase alpha.

Authors:  I Tan; K T Seow; L Lim; T Leung
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

10.  Myotonic dystrophy protein kinase phosphorylates the myosin phosphatase targeting subunit and inhibits myosin phosphatase activity.

Authors:  A Murányi; R Zhang; F Liu; K Hirano; M Ito; H F Epstein; D J Hartshorne
Journal:  FEBS Lett       Date:  2001-03-30       Impact factor: 4.124

View more
  19 in total

1.  Divergent mitochondrial and endoplasmic reticulum association of DMPK splice isoforms depends on unique sequence arrangements in tail anchors.

Authors:  René E M A van Herpen; Ralph J A Oude Ophuis; Mietske Wijers; Miranda B Bennink; Fons A J van de Loo; Jack Fransen; Bé Wieringa; Derick G Wansink
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

2.  Genome modification leads to phenotype reversal in human myotonic dystrophy type 1 induced pluripotent stem cell-derived neural stem cells.

Authors:  Guangbin Xia; Yuanzheng Gao; Shouguang Jin; S H Subramony; Naohiro Terada; Laura P W Ranum; Maurice S Swanson; Tetsuo Ashizawa
Journal:  Stem Cells       Date:  2015-06       Impact factor: 6.277

Review 3.  Myotonic dystrophy kinase-related Cdc42-binding kinases (MRCK), the ROCK-like effectors of Cdc42 and Rac1.

Authors:  Zhuoshen Zhao; Ed Manser
Journal:  Small GTPases       Date:  2015-06-19

Review 4.  Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy.

Authors:  N Muge Kuyumcu-Martinez; Thomas A Cooper
Journal:  Prog Mol Subcell Biol       Date:  2006

5.  Genome Therapy of Myotonic Dystrophy Type 1 iPS Cells for Development of Autologous Stem Cell Therapy.

Authors:  Yuanzheng Gao; Xiuming Guo; Katherine Santostefano; Yanlin Wang; Tammy Reid; Desmond Zeng; Naohiro Terada; Tetsuo Ashizawa; Guangbin Xia
Journal:  Mol Ther       Date:  2016-05-12       Impact factor: 11.454

6.  Comparative transcriptional and biochemical studies in muscle of myotonic dystrophies (DM1 and DM2).

Authors:  Sergio Salvatori; Sandra Furlan; Marina Fanin; Anne Picard; Ebe Pastorello; Vincenzo Romeo; Carlo Pietro Trevisan; Corrado Angelini
Journal:  Neurol Sci       Date:  2009-03-27       Impact factor: 3.307

7.  Structure of dystrophia myotonica protein kinase.

Authors:  Jonathan M Elkins; Ann Amos; Frank H Niesen; Ashley C W Pike; Oleg Fedorov; Stefan Knapp
Journal:  Protein Sci       Date:  2009-04       Impact factor: 6.725

8.  In vivo assessment of muscle membrane properties in myotonic dystrophy.

Authors:  S Veronica Tan; Werner J Z'graggen; Delphine Boërio; Christopher Turner; Michael G Hanna; Hugh Bostock
Journal:  Muscle Nerve       Date:  2016-05-24       Impact factor: 3.217

9.  A tail-anchored myotonic dystrophy protein kinase isoform induces perinuclear clustering of mitochondria, autophagy, and apoptosis.

Authors:  Ralph J A Oude Ophuis; Mietske Wijers; Miranda B Bennink; Fons A J van de Loo; Jack A M Fransen; Bé Wieringa; Derick G Wansink
Journal:  PLoS One       Date:  2009-11-25       Impact factor: 3.240

10.  Design and analysis of effects of triplet repeat oligonucleotides in cell models for myotonic dystrophy.

Authors:  Anchel González-Barriga; Susan Am Mulders; Jeroen van de Giessen; Jeroen D Hooijer; Suzanne Bijl; Ingeborg Dg van Kessel; Josee van Beers; Judith Ct van Deutekom; Jack Am Fransen; Bé Wieringa; Derick G Wansink
Journal:  Mol Ther Nucleic Acids       Date:  2013-03-19       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.